Denali Therapeutics Inc. - DNLI

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 24
Latest filed: Apr 03, 2026
Form Count
8-K 9
144 7
4 6
SCHEDULE 13G/A 2

Latest files

Filed Form Report period Accession SEC
Apr 03, 2026 8-K Apr 03, 2026 0001714899-26-000042 View
Mar 31, 2026 8-K Mar 27, 2026 0001714899-26-000036 View
Mar 26, 2026 SCHEDULE 13G/A — 0000102909-26-001186 View
Mar 25, 2026 8-K Mar 25, 2026 0001714899-26-000030 View
Feb 26, 2026 8-K Feb 26, 2026 0001714899-26-000020 View
Feb 05, 2026 144 — 0001950047-26-000957 View
Feb 04, 2026 144 — 0001950047-26-000923 View
Feb 03, 2026 144 — 0001950047-26-000895 View
Jan 08, 2026 4 Jan 06, 2026 0001724311-26-000005 View
Jan 08, 2026 4 Jan 06, 2026 0001724310-26-000004 View
Jan 06, 2026 8-K Jan 06, 2026 0001714899-26-000004 View
Jan 06, 2026 144 — 0001724310-26-000003 View
Jan 06, 2026 144 — 0001724311-26-000004 View
Jan 06, 2026 144 — 0001724605-26-000004 View
Jan 05, 2026 4 Jan 03, 2026 0001724310-26-000001 View
Jan 05, 2026 4 Jan 03, 2026 0001724311-26-000001 View
Dec 15, 2025 4 Dec 11, 2025 0001193125-25-319291 View
Dec 10, 2025 8-K Dec 09, 2025 0001628280-25-056363 View
Dec 04, 2025 8-K Dec 04, 2025 0001714899-25-000208 View
Dec 04, 2025 8-K Dec 04, 2025 0001714899-25-000209 View
Dec 04, 2025 144 — 0001950047-25-009799 View
Nov 06, 2025 8-K Nov 06, 2025 0001714899-25-000192 View
Nov 06, 2025 4 Nov 04, 2025 0001816206-25-000007 View
Nov 05, 2025 SCHEDULE 13G/A — 0000315066-25-002719 View